Mark A. Jensen

2.9k total citations · 1 hit paper
56 papers, 2.3k citations indexed

About

Mark A. Jensen is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Mark A. Jensen has authored 56 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 14 papers in Pathology and Forensic Medicine and 12 papers in Oncology. Recurrent topics in Mark A. Jensen's work include Multiple Sclerosis Research Studies (12 papers), Systemic Lupus Erythematosus Research (12 papers) and T-cell and B-cell Immunology (12 papers). Mark A. Jensen is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Systemic Lupus Erythematosus Research (12 papers) and T-cell and B-cell Immunology (12 papers). Mark A. Jensen collaborates with scholars based in United States, Germany and Australia. Mark A. Jensen's co-authors include Avertano Noronha, Volker Diehl, Oliver Manzke, U. Winkler, Andreas Engert, Barry G.W. Arnason, H. Schulz, Anthony T. Reder, Timothy B. Niewold and Jens Lund and has published in prestigious journals such as Journal of Neuroscience, Blood and The Journal of Immunology.

In The Last Decade

Mark A. Jensen

56 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)

1999 516 citations U. Winkler, Mark A. Jensen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Jensen United States	25	996	825	518	356	329	56	2.3k
Joanne Jones United Kingdom	32	1.4k 1.4×	1.8k 2.2×	804 1.6×	470 1.3×	505 1.5×	64	3.5k
Takashi Machii Japan	25	760 0.8×	269 0.3×	334 0.6×	360 1.0×	621 1.9×	86	2.1k
Bing He Sweden	25	1.1k 1.1×	549 0.7×	443 0.9×	278 0.8×	962 2.9×	86	2.8k
Masafumi Ito Japan	31	666 0.7×	369 0.4×	575 1.1×	310 0.9×	1.2k 3.7×	175	3.9k
Moon L. Shin United States	31	1.1k 1.1×	442 0.5×	179 0.3×	113 0.3×	614 1.9×	54	2.1k
Andrea Brendolan Italy	22	1.5k 1.5×	462 0.6×	488 0.9×	217 0.6×	1.6k 4.7×	35	3.5k
Robert W. McMurray United States	33	996 1.0×	233 0.3×	362 0.7×	1.0k 2.9×	375 1.1×	63	2.6k
Marco Forni Italy	30	604 0.6×	275 0.3×	533 1.0×	88 0.2×	813 2.5×	93	2.5k
Julie Wheway Australia	14	1.4k 1.4×	187 0.2×	240 0.5×	436 1.2×	352 1.1×	15	2.5k
Laura Leyva Spain	24	543 0.5×	620 0.8×	241 0.5×	466 1.3×	232 0.7×	71	1.7k

Countries citing papers authored by Mark A. Jensen

Since Specialization

Citations

This map shows the geographic impact of Mark A. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Jensen more than expected).

Fields of papers citing papers by Mark A. Jensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Jensen. The network helps show where Mark A. Jensen may publish in the future.

Co-authorship network of co-authors of Mark A. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Jensen. A scholar is included among the top collaborators of Mark A. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Jensen. Mark A. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Yin, Nicholas Geraci, Petra Budde, et al.. (2024). TLR7/8 Activation in Immune Cells and Muscle by RNA‐Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis. Arthritis & Rheumatology. 77(2). 190–201. 6 indexed citations

Kumar, Satyendra, Shinji L. Okitsu, Qi An, et al.. (2023). Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseases. Frontiers in Immunology. 14. 1106537–1106537. 6 indexed citations

Iwamoto, Taro, Jessica M. Dorschner, Shanmugapriya Selvaraj, et al.. (2021). High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis. The Journal of Rheumatology. 49(4). 388–397. 25 indexed citations

Ghodke‐Puranik, Yogita, Zhongbo Jin, Kip D. Zimmerman, et al.. (2021). Single-cell expression quantitative trait loci (eQTL) analysis of SLE-risk loci in lupus patient monocytes. Arthritis Research & Therapy. 23(1). 290–290. 9 indexed citations

Puranik, Amrutesh S., Irina A. Leaf, Mark A. Jensen, et al.. (2018). Kidney-resident macrophages promote a proangiogenic environment in the normal and chronically ischemic mouse kidney. Scientific Reports. 8(1). 13948–13948. 78 indexed citations

Jensen, Mark A., et al.. (2017). Safe Opioid Prescripting: A SMART on FHIR Approach to Clinical Decision Support. Online Journal of Public Health Informatics. 9(2). e193–e193. 20 indexed citations

Jensen, Mark A. & Timothy B. Niewold. (2014). Interferon regulatory factors: critical mediators of human lupus. Translational research. 165(2). 283–295. 31 indexed citations

Jensen, Mark A., Quinn P. Fitzgibbon, CG Carter, & Louise R. Adams. (2013). Effect of body mass and activity on the metabolic rate and ammonia-N excretion of the spiny lobster Sagmariasus verreauxi during ontogeny. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 166(1). 191–198. 31 indexed citations

Waele, Jan J. De, José M. Tellado, Jeff Alder, et al.. (2012). Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study. International Journal of Antimicrobial Agents. 41(1). 57–64. 17 indexed citations

10.

Jensen, Mark A., Karen Patterson, Akaash Kumar, et al.. (2012). Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients. Annals of the Rheumatic Diseases. 72(4). 596–601. 29 indexed citations

11.

Sarav, Menaka, Ying Wang, Bradley K. Hack, et al.. (2009). Renal FcRn Reclaims Albumin but Facilitates Elimination of IgG. Journal of the American Society of Nephrology. 20(9). 1941–1952. 96 indexed citations

12.

White, David M., et al.. (2001). Design and Expression of Polymeric Immunoglobulin Fusion Proteins: A Strategy for Targeting Low-Affinity Fcγ Receptors. Protein Expression and Purification. 21(3). 446–455. 6 indexed citations

13.

Jensen, Mark A., et al.. (1999). Cytokine Secretion by γδ and αβ T cells in Monophasic Experimental Autoimmune Encephalomyelitis. Journal of Autoimmunity. 12(2). 73–80. 12 indexed citations

14.

Jensen, Mark A., U. Winkler, Oliver Manzke, Volker Diehl, & Andreas Engert. (1998). Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab). Annals of Hematology. 77(1-2). 89–91. 81 indexed citations

15.

Sato, Shigeru, Steven L. Reiner, Mark A. Jensen, & Raymond P. Roos. (1997). Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection. Journal of Neuroimmunology. 76(1-2). 213–223. 37 indexed citations

16.

Lü, Chuanzhen, Mark A. Jensen, & Barry G.W. Arnason. (1993). Interferon γ- and interleukin-4-secreting cells in multiple sclerosis. Journal of Neuroimmunology. 46(1-2). 123–128. 66 indexed citations

17.

Noronha, Avertano, et al.. (1992). Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis. Annals of Neurology. 31(1). 103–106. 43 indexed citations

18.

Jensen, Mark A., et al.. (1992). Preferential increase of IL-2R+ CD4+ T cells and CD45RB− CD4+ T cells in the central nervous system in experimental allergic encephalomyelitis. Journal of Neuroimmunology. 38(3). 255–261. 21 indexed citations

19.

Lund, Jens, Mark A. Jensen, & E Hjelms. (1991). Aneurysm of the ductus arteriosus A review of the literature and the surgical implications. European Journal of Cardio-Thoracic Surgery. 5(11). 566–570. 76 indexed citations

20.

Jensen, Mark A., Frank Blecha, & Robert H Hines. (1983). Effect of fluctuating hot temperatures on performance and immunity in finishing pigs. Kansas Agricultural Experiment Station Research Reports. 106–109. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact